Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Agenus Announces Appointment of Tom Harrison to Board of Directors
-
Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Clinical Trial of Reproxalap
-
BDR announces inspirational keynote speakers for SPARK 2025
-
THORNE NAMES MARY BEECH AS CHIEF GROWTH OFFICER
-
TKO Reports Record Second Quarter 2024 Results
-
Settle Launches First Accounts Payable Solution to Automate Landed Costs for CPG Brands
-
First Mining Announces 2024 Second Quarter Financial Results and Operating Highlights
-
Global Bridge Associates Announce New Partnerships and Website to Support Student Homestay Business Expansion
-
Palmer Square Capital BDC Inc. Announces Second Quarter 2024 Financial Results
-
Insmed Reports Second-Quarter 2024 Financial Results and Provides Business Update
-
Agenus Reports Second Quarter 2024 Operational and Financial Results
-
Veritone Announces Strategic Collaboration Agreement with AWS to Unlock AI at Scale
-
Nexstar Media Group Reports Record Second Quarter Net Revenue of $1.27 Billion
-
Perion Network Announces Conference Participation in August-September 2024
-
Shift4 Announces Second Quarter 2024 Results
-
ProcessUnity Accelerator for EU DORA Compliance Enhances Third-Party Risk Management and Operational Resilience
-
Cheniere Partners Reports Second Quarter 2024 Results and Reconfirms Full Year 2024 Distribution Guidance
-
Laser Photonics Shares Concept Animation of Laser Shield Anti-Drone System (LSAD)
-
Papa Johns Announces Second Quarter 2024 Financial Results
-
The Cannabist Company Reports Second Quarter 2024 Results
-
Origin Materials and Reed City Group Announce North American Mass Production Partnership for PET Caps and Closures
-
Hippo Reports Second Quarter 2024 Financial Results
-
Scholar Rock Reports Second Quarter 2024 Financial Results and Highlights Business Progress
-
Satellos Receives Rare Pediatric Disease Designation from the U.S. FDA for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy
-
Amylyx Pharmaceuticals Reports Second Quarter 2024 Financial Results
-
Pegasus Tech Ventures Launches Partnership With Japanese Snack Food Giant Calbee
-
CGI's latest Momentum® release delivers advanced AI capabilities to help federal agencies streamline operations
-
Lifetime Brands, Inc. Reports Second Quarter 2024 Financial Results
-
Apellis and Sobi Announce Positive Topline Results from Phase 3 VALIANT Study of Pegcetacoplan in C3G and Primary IC-MPGN
-
Royalty Pharma Reports Second Quarter 2024 Results
-
Alphakek AI Expands to Base Network with Launch of $AIKEK Token
-
RYVYL Licenses its Payment Platform as a Service (“PPaaS”) to a U.S. National Payment Processor
-
Bio-Path Holdings to Announce Second Quarter 2024 Financial Results on August 15, 2024
-
One Equity Partners Completes Sale of ORS Nasco
-
Tecnoglass Reports Second Quarter 2024 Results
-
Autolus Therapeutics Reports Second Quarter 2024 Financial Results and Business Updates
-
Village Farms International Reports Q2/24 Results
-
AltruPay Announced As Sponsor Of 2024 DFW Youth World Baseball Classic
-
LENSAR Reports Second Quarter 2024 Results and Provides Business Update
-
Federal Circuit Affirms Invalidation of Miller Mendel Patent Claims
-
Sterling Reports Second Quarter 2024 Results
-
Bitfarms Reports Second Quarter 2024 Results
-
ProMIS Neurosciences Announces Second Quarter 2024 Financial Results and Recent Highlights
-
Roivant Reports Financial Results for the First Quarter Ended June 30, 2024, and Provides Business Update
-
Axogen, Inc. Reports Second Quarter 2024 Financial Results
-
Zapata AI Announces Timing of its Second Quarter 2024 Results Conference Call
-
Kaltura Announces Financial Results for Second Quarter 2024
-
Plug Power Announces Key Developments and Strategic Milestones in Second Quarter 2024
-
Timeusb Releases 3 LiFePO4 Batteries at a Fresh Start
-
Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
